Table 2

Association of NSAIDs intake with radiographic spinal progression (mSASSS change ≥2 over 2 years) in patients with AS and non-radiographic axial SpA in the multivariate logistic regression analysis

AS (n=88)Non-radiographic axial SpA (n=76)
ParametersOR (95% CI)p ValueOR (95% CI)p Value
NSAID intake index over 2 years, >50 vs ≤500.15 (0.02 to 0.96)0.0450.60 (0.06 to 6.61)0.679
Syndesmophytes at baseline, present vs not present6.80 (1.78 to 25.95)0.00515.4 (2.59 to 91.7)0.003
CRP at baseline, >6 vs ≤6 mg/l1.34 (0.37 to 4.93)0.6560.37 (0.03 to 4.36)0.432
Smoking status at baseline, present vs not present3.45 (0.97 to 12.23)0.0551.01 (0.14 to 7.26)0.989
R-square=0.289R-square=0.268
  • AS, ankylosing spondylitis; CRP, C reactive protein; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score; NSAID, non-steroidal anti-inflammatory drug; SpA, spondyloarthritis.